Internal Venom Peptide Research

About Smartox Biotechnology

Founded in 2011 and based in Grenoble, France, Smartox Biotechnology operates at the intersection of neuroscience, small molecules, and drug delivery by mining animal venoms for therapeutic peptides. The company has a dual business model, providing both research tools (a catalog of toxins and custom synthesis services) and drug discovery services (its VenomScreen library and hit-to-lead programs) to pharmaceutical and academic partners. As a private company, it appears to be in an early revenue stage, commercializing its platform while potentially advancing internal or partnered discovery programs. Its core value proposition is turning the complex molecular diversity of venoms into validated starting points for novel drug candidates.

Therapeutic Areas

Other Not specified Drugs